# Nimodipine

## Nimotop inj 10mg/ 50mL

##### 

| Title              | Content                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | INIM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Indications        | Prophylaxis & treatment of ischaemic neurological deficits caused by cerebral vasospasms following subarachnoid haemorrhage.                                                                                                                                                                                                                                                                                                                                                                                                               |
| Dosing             | Subarachnoid hemorrhage， From ruptured intracranial berry aneurysms prophylaxis: initial， 0.5 mg/hr (hemadynamics unstable patient) to 1mg/hr (15mcg/kg/hr) for 2hr， then slowly titrate to 2mg/hr. (usually start drug within 4 days， then keep therapy for10-14days. if Craniotomy: continue IVD for at least 5 days after craniotomy. Then switch to ORALLY 60mg q4h for 7 days. treatment: initial， 1mg/hr (15mcg/kg/hr) for 2hr， then slowly titrate to 2mg/hr for 5-14days. after that， switch to ORALLY 60mg q4h for 7 days. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Contraindications  | Must not be administered to patients with severely impaired liver function                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Adverse Effects    | Hypotension， GI disturbances.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Pregnancy          | No (limited) human data – animal data suggest risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

## Nimotop F.C 30mg

##### 

| Title              | Content                                                                                                                                                                                               |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | ONIM                                                                                                                                                                                                  |
| Indications        | Prophylaxis & treatment of ischaemic neurological deficits caused by cerebral vasospasms following subarachnoid haemorrhage.                                                                          |
| Dosing             | Subarachnoid hemorrhage， From ruptured intracranial berry aneurysms: treatment or prophylaxis: 60mg Q4H for 7 days (1 hour before or 2 hours after meals)， after IV infusion Nimotop for 5-14 days. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                         |
| Contraindications  | Patients with severely impaired liver function (eg， cirrhosis of the liver). In view of its indication area， Nimotop tablet is not used during pregnancy or lactation.                              |
| Adverse Effects    | Hypotension， GI disturbances.                                                                                                                                                                        |
| Pregnancy          | No (limited) human data – animal data suggest risk                                                                                                                                                    |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                         |

